Lataa...
Cost-effectiveness and budget impact of the fixed-dose dual bronchodilator combination tiotropium–olodaterol for patients with COPD in the Netherlands
PURPOSE: The fixed-dose dual bronchodilator combination (FDC) of tiotropium and olodaterol showed increased effectiveness regarding lung function and health-related quality of life in patients with chronic obstructive pulmonary disease (COPD) compared with the use of its mono-components. Yet, while...
Tallennettuna:
| Julkaisussa: | Int J Chron Obstruct Pulmon Dis |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5036592/ https://ncbi.nlm.nih.gov/pubmed/27703341 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S114738 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|